Literature DB >> 30462172

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on the Incidence of All-cause Pneumonia in Adults Aged ≥60 Years: A Population-based, Retrospective Cohort Study.

Martin Kolditz1, Jochen Schmitt2, Mathias W Pletz3, Falko Tesch2.   

Abstract

In this population-based study evaluating the effectiveness of the 13-valent pneumococcal conjugate vaccine (2012-2016) to prevent all-cause pneumonia in adults ≥60 years of age, we found significant, 0.63% absolute risk and 11.9% relative risk reductions on the 3-year (2014-2016) cumulative incidences of all-cause pneumonia after vaccination.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  elderly; pneumococcal vaccination; pneumonia; prevention

Mesh：

Substances：

Year:  2019        PMID： 30462172     DOI： 10.1093/cid/ciy993

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  8 in total

1.  Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study.

Authors:  Claire von Mollendorf; Mukhchuluun Ulziibayar; Bradford D Gessner; Lien Anh Ha Do; Cattram D Nguyen; Rohini Beavon; Bujinlkham Suuri; Dashtseren Luvsantseren; Dorj Narangerel; Adam Jenney; Eileen M Dunne; Catherine Satzke; Badarchiin Darmaa; Tuya Mungun; E Kim Mulholland
Journal:  BMC Public Health       Date:  2021-09-23       Impact factor: 3.295

2.  Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.

Authors:  Raul Isturiz; Lindsay Grant; Sharon Gray; Ronika Alexander-Parrish; Qin Jiang; Luis Jodar; Paula Peyrani; Kimbal D Ford; Michael W Pride; Wesley H Self; Francis Counselman; Gregory Volturo; Luis Ostrosky-Zeichner; Richard G Wunderink; Robert Sherwin; J Scott Overcash; Thomas File; Julio Ramirez
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999

Review 3.  [Development and progress in respiratory tract infections].

Authors:  Mathias W Pletz
Journal:  Pneumologe (Berl)       Date:  2022-02-11

4.  Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine.

Authors:  Amber Hsiao; John Hansen; Julius Timbol; Ned Lewis; Raul Isturiz; Ronika Alexander-Parrish; John M McLaughlin; Bradford D Gessner; Nicola P Klein
Journal:  JAMA Netw Open       Date:  2022-03-01

Review 5.  A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population.

Authors:  Jacob Dag Berild; Brita Askeland Winje; Didrik Frimann Vestrheim; Hans-Christian Slotved; Palle Valentiner-Branth; Adam Roth; Jann Storsäter
Journal:  Pathogens       Date:  2020-04-03

6.  Effectiveness of pneumococcal conjugate vaccination against virus-associated lower respiratory tract infection among adults: a case-control study.

Authors:  Joseph A Lewnard; Katia J Bruxvoort; Vennis X Hong; Lindsay R Grant; Luis Jódar; Alejandro Cané; Bradford D Gessner; Sara Y Tartof
Journal:  J Infect Dis       Date:  2022-03-22       Impact factor: 7.759

7.  [Prevention by vaccination of adult patients with pulmonary diseases].

Authors:  Carolin Dodt; Mathias W Pletz; Martin Kolditz
Journal:  Pneumologe (Berl)       Date:  2021-07-12

Review 8.  [Pneumococcal vaccination].

Authors:  Mathias W Pletz; Christina Bahrs
Journal:  Internist (Berl)       Date:  2021-07-12       Impact factor: 0.743
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.